Ernesto Cano

1.2k citations

38 papers · 1.0k indexed · h-index 18

Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine 5
Organic Chemistry top 5%
- Synthesis and biological activity 11
- Synthesis and Reactions of Organic Compounds 11
- Chemical synthesis and pharmacological studies 6
- Synthesis and Reactivity of Heterocycles 5
Biological Psychiatry
Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 6
Pharmacology top 10%
Hematology
- Platelet Disorders and Treatments 4
Molecular Biology
- Phenothiazines and Benzothiazines Synthesis and Activities 4

Co-authors: Nuria Fraiz Matilde Yáñez Francisco Orallo Reyes Laguna Enrique Raviña Eddy Sotelo Eugenio Uriarte Lourdes Santana
Cited by: Geriatrics and Gerontology Organic Chemistry Biological Psychiatry
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Archiv der Pharmazie (4 papers)European Journal of Medicinal Chemistry (2 papers)
Partner nations: Spain France United States

In The Last Decade

Ernesto Cano

37 papers receiving 1.0k citations

Peers

Countries citing papers authored by Ernesto Cano

Since Specialization

Citations

This map shows the geographic impact of Ernesto Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Cano more than expected).

Fields of papers citing papers by Ernesto Cano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Cano. The network helps show where Ernesto Cano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ernesto Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ernesto Cano Line = papers co-authored together Ernesto Cano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Stilbene-pyridazinone hybrids: design, synthesis and in vitro antiplatelet activity screening Bioorganic Chemistry ·V. Von Motschulsky,Pedro Besada,Ricardo A. Mosquera,Ernesto Cano,Carmen Terán	2024	3
2	2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: Design, synthesis, and SAR studies Bioorganic & Medicinal Chemistry Letters ·Caroline Meyers,Matilde Yáñez,Marcello Gaita,S. E. Burdall,Alberto Coelho,Nuria Fraiz,Guy L. F. Lemière,Xerardo García‐Mera,Reyes Laguna,Ernesto Cano,Bert U. W. Maes,Eddy Sotelo	2007	10
3	(−)-Trans-ε-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity European Journal of Pharmacology ·Matilde Yáñez,Nuria Fraiz,Ernesto Cano,Francisco Orallo	2006	32
4	Differential regulation of platelet aggregation and aminophospholipid exposure by calpain British Journal of Haematology ·Christilla Bachelot‐Loza,Amber Cook,Brigitte Brohard-Bohn,Nuria Fraiz,Ernesto Cano,Francine Rendu	2006	11
5	Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity Biochemical and Biophysical Research Communications ·Matilde Yáñez,Nuria Fraiz,Ernesto Cano,Francisco Orallo	2006	172
6	Pyridazines part 41: Synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones Bioorganic & Medicinal Chemistry Letters ·H. Arque Almaraz,Caroline Meyers,Alberto Coelho,Matilde Yáñez,Nuria Fraiz,Eddy Sotelo,Bert U. W. Maes,Reyes Laguna,Ernesto Cano,Guy L. F. Lemière,Enrique Raviña	2005	17
7	β-Hexosaminidase isoenzyme profiles in serum, plasma, platelets and mononuclear, polymorphonuclear and unfractionated total leukocytes Clinical Biochemistry ·J. Casal,Ernesto Cano,J. Carlos Tutor	2005	7
8	Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin–resveratrol hybrids Bioorganic & Medicinal Chemistry Letters ·Santiago Vilar,Elías Quezada,Lourdes Santana,Eugenio Uriarte,Matilde Yáñez,Nuria Fraiz,Carlos Alcaide,Ernesto Cano,Francisco Orallo	2005	139
9	Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages International Immunopharmacology ·J. Leiro,Ezequiel Álvarez,J.A. Arranz,Ernesto Cano,Francisco Orallo	2003	52
10	Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions Bioorganic & Medicinal Chemistry ·Eddy Sotelo,Nuria Fraiz,Matilde Yáñez,J.H. Tait,Reyes Laguna,Ernesto Cano,Enrique Raviña	2002	78
11	Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors Bioorganic & Medicinal Chemistry Letters ·Eddy Sotelo,Nuria Fraiz,Matilde Yáñez,Reyes Laguna,Ernesto Cano,José Brea,Enrique Raviña	2002	29
12	Pyridazines. Part 28. 5‐Alkylidene‐6‐phenyl‐3(2H)‐pyridazinones, a New Family of Platelet Aggregation Inhibitors. ChemInform ·Eddy Sotelo,Nuria Fraiz,Matilde Yáñez,Reyes Laguna,Ernesto Cano,José Brea,Enrique Raviña	2002	1
13	Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activation FEBS Letters ·Danah I. AlKandari,Alaka Chiplonkar,Hervé Falet,Brigitte Brohard-Bohn,Nuria Fraiz,Christilla Bachelot‐Loza,Ernesto Cano,Francine Rendu	1999	7
14	AM1 theoretical study, synthesis and biological evaluation of some benzofuran analogues of anti-inflammatory arylalkanoic acids European Journal of Pharmaceutical Sciences ·Lourdes Santana,Marta Teijeira,Eugenio Uriarte,Carmen Terán,H. Kenchington,Priscila Eunice Ascensao Lopo,Reyes Laguna,Ernesto Cano	1999	40
15	Pyridazines. XVIII. 6-Aryl-3(2H)-Pyridazinones Inhibit Calcium Influx in Stimulated Platelets. Biological and Pharmaceutical Bulletin ·Susan Jean Youell,Nuria Fraiz,Reyes Laguna,Ernesto Cano,Daniel Landínez,Enrique Raviña	1999	19
16	Pyridazines. XIII. Synthesis of 6-Aryl-5-Oxygenated Substituted-3(2H)-Pyridazinones and Evaluation as Platelet Aggregation Inhibitors. Chemical and Pharmaceutical Bulletin ·Reyes Laguna,Christopher S Strager,Ernesto Cano,Daniel Landínez,Enrique Raviña,Eddy Sotelo	1997	31
17	Pharmacological Effects of Three Phenylpropanoid Glycosides fromMussatia Planta Medica ·Ernesto Cano,Manuel Veiga,Carlos Jiménez,Ricardo Riguera	1990	29
18	Phenanthrylalkanoic Acids, IV¹⁾: Syntheses and Antiinflammatory Activity of 2‐, 3‐, and 9‐Phenanthryl‐ and 9‐Chloro‐3‐phenanthryl Derivatives of Propanoic Acid Archiv der Pharmazie ·Franco Fernández,Carmen González,Generosa Gómez,Carmen López,Timothy Brook,J. M. Calleja,Ernesto Cano	1990	4
19	Role of PAF-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021 International Journal of Immunopharmacology ·S. Fernández-Gallardo,Ernesto Cano,P. Braquet,Mariano Sánchez Crespo	1988	4
20	Intracellular localization of platelet-activating factor synthesis in human neutrophils Biochemical and Biophysical Research Communications ·Faustino Mollinedo,Julián Gómez-Cambronero,Ernesto Cano,Mariano Sánchez Crespo	1988	31

About Ernesto Cano

Ernesto Cano is a scholar working on Toxicology, Geriatrics and Gerontology, Biological Psychiatry, Physiology and Organic Chemistry, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Synthesis and biological activity (11 papers), Synthesis and Reactions of Organic Compounds (11 papers), Bioactive Compounds and Antitumor Agents (6 papers), Chemical synthesis and pharmacological studies (6 papers), Synthesis and Reactivity of Heterocycles (5 papers), Sirtuins and Resveratrol in Medicine (5 papers), Platelet Disorders and Treatments (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). The work is most often cited by research in Geriatrics and Gerontology (76 citations), Organic Chemistry (539 citations), Biological Psychiatry (23 citations), Toxicology (31 citations) and Pharmacology (147 citations). Ernesto Cano has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Nuria Fraiz, Matilde Yáñez, Francisco Orallo, Reyes Laguna, Enrique Raviña, Eddy Sotelo, Eugenio Uriarte, Lourdes Santana, Elías Quezada and Carlos Alcaide. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Archiv der Pharmazie, European Journal of Medicinal Chemistry, Chemical and Pharmaceutical Bulletin and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact